文献速递心力衰竭与心肌病瓣膜病与结构性心脏病肺血管病与心包/心肌炎

植入式血流动力学监测在主动脉下右心室成人中的新用途

Novel uses for implanted haemodynamic monitoring in adults with subaortic right ventricles.
PubMed 文献 · Heart · 2024-03-12

本研究回顾性分析了单中心2015-2022年18例主动脉下右心室成人患者中植入式侵入性血流动力学监测(IHM)的应用。IHM用于药物滴定、心室辅助装置后管理及无创监测肺动脉压力以确定心脏移植转诊时机。随访中位23个月,心衰住院率与IHM前相比无显著差异,发生1例装置移位但无长期后遗症。

要点

  • IHM可用于主动脉下右心室患者的药物滴定和肺动脉压力序列监测。
  • IHM可能减少反复心导管检查的需求,尤其在肺动脉高压高发人群。
  • IHM未显著影响心衰住院率,装置相关并发症少见。

核心结论

  • IHM在主动脉下右心室患者中有多种新用途,可能减少序列心导管检查需求,但未改变心衰住院率。

研究设计与样本

  • 回顾性单中心研究,纳入2015-2022年18例主动脉下右心室成人患者,中位年龄43岁(范围30-54),其中16例为D-TGA/AS,2例为ccTGA。

主要发现

  • 18例患者中16例存在中度或重度右心室收缩功能障碍,13例导管检查证实肺动脉高压。
  • IHM用于药物滴定、心室辅助装置后管理及无创监测肺动脉压力以确定心脏移植转诊时机。
  • 随访中位23个月,心衰住院率与IHM前一年相似(中位0次/年(IQR 0-1.0) vs 0次/年(0-0.8),p=0.984)。
  • 发生1例装置移位,无长期后遗症。

临床怎么用

  • 对于主动脉下右心室患者,可考虑使用IHM进行血流动力学监测以减少反复导管检查。
  • IHM可用于指导药物滴定和心室辅助装置后管理及移植转诊时机评估。

局限性

  • 回顾性单中心设计,样本量小(18例),随访时间有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary hypertension (PH) is a common complication in patients with complete dextro-transposition of the great arteries (TGA) after atrial switch (D-TGA/AS) and congenitally corrected TGA (ccTGA). In this population with subaortic right ventricles (sRVs), echocardiography is a poor screening tool for PH; implantable invasive haemodynamic monitoring (IHM) could be used for this purpose, but data are limited. The aim of this study is to report on novel uses of IHM in patients with sRV. METHODS: This retrospective study describes the uses of IHM, impact of IHM on heart failure hospitalisation (HFH) and device-related complications in adults with sRV from a single centre (2015-2022). RESULTS: IHM was placed in 18 patients with sRV (median age 43 (range 30-54) years, 8 female, 16 with D-TGA/AS, 2 with ccTGA); 16 had moderate or severe sRV systolic dysfunction, 13 had PH on catheterisation. IHM was used for (1) Medical therapy titration, (2) Medical management after ventricular assist device in patients with transplant-limiting PH and (3) Serial monitoring of pulmonary artery pressures without repeat catheterisations to help identify the optimal time for heart transplant referral. In follow-up (median 23 months), HFHs/year were similar to the year prior to IHM (median 0 (IQR 0-1.0) before vs 0 (0-0.8) after, p=0.984). Device migration occurred in one, without long-term sequelae. CONCLUSIONS: Uses of IHM in patients with sRV are described which may minimise the need for serial catheterisations in a population where PH is prevalent. HFHs were low overall but not impacted by IHM. One device-related complication occurred without long-term consequence.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Marshall V WH, Mah ML, DeSalvo J, et al. Novel uses for implanted haemodynamic monitoring in adults with subaortic right ventricles. Heart. 2024. PMID: 37935570. doi:10.1136/heartjnl-2023-323206

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。